Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page without changing study details or layout.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a new revision label: v3.6.5 instead of v3.6.4, indicating a small update to the page's documentation or metadata.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This appears to be a small backend/UI update.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, signaling a new build of the page.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page’s revision tag changed from v3.6.0 to v3.6.2, reflecting a minor template/backend update that does not modify the study details.SummaryDifference0.0%

- Check87 days agoChange DetectedThe study page now shows recruitment is closed with 'No longer looking for participants', and new help sections were added to guide users (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, a formatting label changed from 'Intervention / Treatment' to 'Intervention/Treatment' and the page revision is updated to v3.6.0, replacing v3.5.5.SummaryDifference0.3%

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.